|
Malyavin A.G., Avksentieva M.V., Babak S.L., Dzanaeva A.V.
Medical and economical consequences of extension of medicamentally support program for patients with COPD in Russia
|
№5 / 2019
|
|
Adasheva T.V., Bolieva L.Z., Lee V.V., Malyavin A.G.
Use of beta-blockers in COPD: mythical risk or justified benefit?
|
№5 / 2019
|
|
Zhdankin A.V., Nikishkina D.R., Solodun M.V.
Clinical case of tumor in a rare localization
|
№4 / 2019
|
|
Epishina Ya.S., Khazov D.A., Solodun M.V.
Clinical case of the bronchial obstruction syndrome: COPD or asthma?
|
№3 / 2019
|
|
Statsenko M.E., Lopushkova Yu.E., Derevyanchenko M.V.
Study of arterial stiffness and C-reactive protein level in patients with chronic heart failure and chronic obstructive pulmonary disease
|
№1 / 2019
|
|
S.L. Babak, M.V. Gorbunova, A.G. Malyavin
New strategy of mucolytic therapy in modern medical practice
|
№1 / 2018
|
|
S.N. Avdeev, Z.R. Aysanov, A.S. Belevsky
Сlinical guidelines of Russian respiratory society: algorithm for the management of patients with chronic obstructive pulmonary disease
|
№4 / 2017
|
|
L.I. Dvoretsky, Ye.V. Sergeeva
Antibacterial therapy of copd exacerbations: prescribe or not prescribe
|
№1 / 2017
|
|
Ye.I. Samorukova, T.V. Adasheva, S.V. Pavlov
Correction of systemic inflammation, oxidative stress and antioxidant defense using rosuvastatin in patients with chronic obstructive pulmonary disease
|
№1 / 2017
|
|
N.T. Vatutin, A.S. Smirnova, Ye.S. Gasendich
The evaluation of lipid profile in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease
|
№6 / 2016
|
|
K.I. Tebloev, K.A. Fomina, Ye.V. Zhilyaev, A.A. Spassky
Evaluation of the influence of various factors on progression of chronic obstructive pulmonary disease and bronchial asthma: results of long-term cohort study
|
№5 / 2016
|
|
N.A. Karoli, A.P. Rebrov
Some aspects of pathogenesis and prevention of sudden cardiac death in patients with chronic obstructive pulmonary disease
|
№4 / 2016
|
Русский
